{
    "organizations": [],
    "uuid": "b5ac2eb2183e5c1a5ec53b90c5a4b7482a3031ad",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-indias-natco-pharma-dec-qtr-consol/brief-indias-natco-pharma-dec-qtr-consol-profit-rises-idUSFWN1PW073",
    "ord_in_thread": 0,
    "title": "BRIEF-India's Natco Pharma Dec-Qtr Consol Profit Rises",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 6 (Reuters) - Natco Pharma Ltd:\n* DEC QUARTER CONSOL NET PROFIT 2.18 BILLION RUPEES VERSUS PROFIT 1.95 BILLION RUPEES YEAR AGO\n* RECOMMENDED DIVIDEND OF 7 RUPEES PER SHARE * DEC QUARTER CONSOL REVENUE FROM OPERATIONS 5.62 BILLION RUPEES VERSUS 6.79 BILLION RUPEES YEAR AGO\n* DEC QUARTER CONSOL REVENUE FROM OPERATIONS 5.62 BILLION RUPEES VERSUS 6.79 BILLION RUPEES YEAR AGO Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-06T16:29:00.000+02:00",
    "crawled": "2018-02-07T21:44:34.016+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "natco",
        "pharma",
        "ltd",
        "dec",
        "quarter",
        "consol",
        "net",
        "profit",
        "billion",
        "rupee",
        "versus",
        "profit",
        "billion",
        "rupee",
        "year",
        "ago",
        "recommended",
        "dividend",
        "rupee",
        "per",
        "share",
        "dec",
        "quarter",
        "consol",
        "revenue",
        "operation",
        "billion",
        "rupee",
        "versus",
        "billion",
        "rupee",
        "year",
        "ago",
        "dec",
        "quarter",
        "consol",
        "revenue",
        "operation",
        "billion",
        "rupee",
        "versus",
        "billion",
        "rupee",
        "year",
        "ago",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}